Additionally, enhancing cholinergic neurotransmission through supplementation with AChE inhibitors, such as Donepezil, which is used to treat symptoms of Alzheimer’s disease, could be considered as a therapeutic approach to improve cognitive performance in people with T1DM. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.